Pentwater Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143M Buy
765,000
+640,000
+512% +$118M 0.88% 24
2026
Q1
$23.6M Buy
+125,000
New +$26.3M 0.12% 53
2025
Q4
Sell
-110,000
Closed -$22.3M 121
2025
Q3
$22.3M Buy
+110,000
New +$19.5M 0.12% 63
2017
Q4
Sell
-10,000
Closed -$164K 104
2017
Q3
$164K Buy
+10,000
New +$170K ﹤0.01% 102

Other funds holding THC

Pentwater Capital Management's THC Position: Q2 2026 in Review

Pentwater Capital Management increased its Tenet Healthcare (THC) stake by 512% in Q2 2026, buying an estimated $118M and bringing the position to 765,000 shares worth $143M. The position accounts for 0.88% of the portfolio, ranked #24.

Pentwater Capital Management first reported a position in THC in Q3 2017 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Pentwater Capital Management held 765,000 shares of Tenet Healthcare worth $143M as of Q2 2026.
  • Pentwater Capital Management bought 640,000 Tenet Healthcare shares in Q2 2026, an estimated $118M.
  • Tenet Healthcare made up 0.88% of Pentwater Capital Management's portfolio in Q2 2026, its #24 holding.
  • Pentwater Capital Management first reported a position in Tenet Healthcare in Q3 2017 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.